Decernotinib is a novel, potent, selective and orally available JAK3 inhibitor for the treatment of autoimmune diseases. In terms of production side, this report researches the Decernotinib (JAK3 Inhibitor) production capacity, value, ex-factory price, and growth rate, market share by manufacturers, regions (or countries) and by Type. In terms of consumption side, this report focuses […]
